- Home
- BMRC vs MXCT Comparison
BMRC vs MXCT Comparison
Compare BMRC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRC
- MXCT
- Stock Information
- Founded
- BMRC 1989
- MXCT 1999
- Country
- BMRC United States
- MXCT United States
- Employees
- BMRC N/A
- MXCT N/A
- Industry
- BMRC Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BMRC Finance
- MXCT Health Care
- Exchange
- BMRC Nasdaq
- MXCT Nasdaq
- Market Cap
- BMRC 334.0M
- MXCT 398.3M
- IPO Year
- BMRC N/A
- MXCT 2021
- Fundamental
- Price
- BMRC $25.00
- MXCT $3.41
- Analyst Decision
- BMRC Buy
- MXCT Strong Buy
- Analyst Count
- BMRC 3
- MXCT 3
- Target Price
- BMRC $21.00
- MXCT $8.67
- AVG Volume (30 Days)
- BMRC 76.1K
- MXCT 353.2K
- Earning Date
- BMRC 10-28-2024
- MXCT 11-06-2024
- Dividend Yield
- BMRC 4.00%
- MXCT N/A
- EPS Growth
- BMRC N/A
- MXCT N/A
- EPS
- BMRC N/A
- MXCT N/A
- Revenue
- BMRC $59,368,000.00
- MXCT $45,599,000.00
- Revenue This Year
- BMRC N/A
- MXCT N/A
- Revenue Next Year
- BMRC $14.76
- MXCT $23.47
- P/E Ratio
- BMRC N/A
- MXCT N/A
- Revenue Growth
- BMRC N/A
- MXCT 19.85
- 52 Week Low
- BMRC $14.11
- MXCT $3.15
- 52 Week High
- BMRC $26.19
- MXCT $5.55
- Technical
- Relative Strength Index (RSI)
- BMRC 66.87
- MXCT 38.39
- Support Level
- BMRC $21.72
- MXCT $3.50
- Resistance Level
- BMRC $26.19
- MXCT $4.15
- Average True Range (ATR)
- BMRC 1.02
- MXCT 0.21
- MACD
- BMRC 0.25
- MXCT 0.01
- Stochastic Oscillator
- BMRC 77.70
- MXCT 14.81
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.